PBRT associated with a lower opioid pain requirement and a lower rate of gastrostomy tube dependence
02/02/2016
/
Publications
/
Chemotherapy
IMRT
Chemotherapy
A matched analysis compared PBRT and IMRT for nasopharynx and paranasal sinus cancers with concurrent chemotherapy, reported that PBRT was associated with a...
Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptation.
11/11/2021
/
Publications
/
IMPT
Treatment and acute toxicity data of 17 chordoma and 3 chondrosarcoma patients treated with IMPT were retrospectively evaluated in this study. This study found...
Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy
10/10/2021
/
Publications
Radiation-induced optic neuropathy (RION) is a rare side effect following radiation therapy. A multi-institutional cohort including 289 skull-base cancer...
CT-on-Rails Versus In-Room CBCT for Online Daily Adaptive Proton Therapy of Head-and-Neck Cancers
11/11/2021
/
Publications
/
Dosimetry
This study compared the efficacy of CT-on-rails versus in-room CBCT for daily adaptive proton therapy. CT-on-rails provides high precision accuracies, but the...
A comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
12/12/2021
/
Publications
/
IMPT
VMAT
A cohort of tonsil and salivary gland cancer patients who received ipsilateral curative-intent radiotherapy delivered by IMPT or VMAT were reviewed including...
Proton therapy can be a safe and effective curative reirradiation strategy for head and neck cancer
30/09/2016
/
Publications
/
Toxicity
Reirradiation
Toxicity
Survival
Proton therapy can be a safe and effective curative reirradiation strategy for head and neck cancer, with acceptable rates of toxicity and durable disease...
Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: A cost-effectiveness analysis.
26/11/2021
/
Publications
/
IMPT
IMRT
This is a cost-effectiveness study from China. A Markov model is used with the assumption that IMPT offered NTCP reduction in long-term dysphagia, xerostomia...
Indications for Proton Therapy
29/10/2021
/
Webinar
/
Proton therapy center
Dr. Marcio Fagundes from Baptist Health South Florida talks about Proton Therapy in the Context of Multi-Technology.
Protons at MCI
Treatment Modality...
Model-based for nasopharyngeal carcinoma (Spanish subtitles)
31/08/2020
/
Webinar
/
Model-based approach
IMPT
VMAT
ARC therapy
Prof. Hans Langendijk presents the model-based selection procedure for nasopharyngeal carcinoma, IMPT treatment results compared with IMRT or VMAT treatments...
Meet the expert at ASTRO 2018 with Dr Alexander Lin
22/10/2018
/
Event
/
Model-based approach
Learn with our customers how they turn challenges into opportunities in their daily practice with proton therapy:
"Model-based clinical validation of proton...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.